United Therapeutics (UTHR)’ President Michael Benkowitz disclosed the sale of 10,000 shares of company stock at $370.14 per share on December 16, for a total transaction amount of $3,701,377.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UTHR:
- United Therapeutics management to meet with Oppenheimer
- Hunterbrook goes long Liquidia into trial over lung disease treatment
- Y-mAbs Therapeutics initiated with a Buy at Brookline on Danyelza potential
- United Therapeutics price target raised to $400 from $360 at Argus
- United Therapeutics price target raised to $600 from $575 at Oppenheimer